Exome Asset Management’s Yarrow Bioscience YARW Stock Holding History

Exome Asset Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,179	Closed	-$345K	–	97
2025 Q2	$345K	Sell	4,179 -5,077	-55%	-$330K	0.26%	55
2025 Q1	$731K	Buy	9,256 +2,187	+31%	+$269K	0.65%	43
2024 Q4	$1.18M	Hold	7,069	–	–	0.89%	42
2024 Q3	$664K	Hold	7,069	–	–	0.45%	52
2024 Q2	$696K	Sell	7,069 -1,240	-15%	-$155K	0.62%	43
2024 Q1	$1.28M	Buy	8,309 +5,947	+252%	+$641K	1.09%	42
2023 Q4	$275K	Buy	+2,362	New	+$368K	0.27%	50

Other funds holding YARW

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Exome Asset Management's YARW Position: Q3 2025 in Review

Exome Asset Management sold out of Yarrow Bioscience (YARW) in Q3 2025, closing a stake of 4,179 shares — an estimated $345K sold.

Exome Asset Management first reported a position in YARW in Q4 2023 and held it in 7 quarters. The position peaked at $1.28M in Q1 2024. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

Exome Asset Management reported no remaining Yarrow Bioscience position as of Q3 2025 after selling out during the quarter.
Exome Asset Management sold 4,179 Yarrow Bioscience shares in Q3 2025, an estimated $345K.
Exome Asset Management first reported a position in Yarrow Bioscience in Q4 2023 and held it in 7 quarters.
Exome Asset Management's Yarrow Bioscience position peaked at $1.28M in Q1 2024.
34 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2025.

Based on Exome Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.